Genentech plans $125m expansion of Oregon manufacturing facility

By Zachary Brennan

- Last updated on GMT

Genentech plans $125m expansion of Oregon manufacturing facility

Related tags: Biotechnology

Genentech will invest more than $125m to expand its fill/finish facility in Hillsboro, Oregon. 

"This investment in our sterile production operations will result in the addition of up to 100 new skilled manufacturing jobs in the greater Portland area over the next five years​, potentially bringing the total number of Genentech jobs in Oregon to over 500​," said Larry Sanders, General Manager and Vice President, Hillsboro Technical Operations.

Opened in April 2010, the facility is home to a state-of-the-art fill/finish facility and warehousing and distribution center. Genentech's product pipeline is among the strongest in the biotechnology and pharmaceutical industries, and demand for its marketed products continues to grow. The expansion of operations at the Hillsboro site is part of the company’s strategy to increase manufacturing capacity to meet an increasing demand for its products. 

Historically, Genentech was the first biotech company to scale up protein manufacturing successfully from small quantities used for research to much larger quantities for clinical trials and commercialization. Now Genentech and parent company Roche have more FDA-approved manufacturing capacity for the production of biotech medicines than any other company. 

Related news

Related suppliers